Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar;262(3):679-687.
doi: 10.1007/s00417-023-06264-1. Epub 2023 Oct 16.

Proliferative vitreoretinopathy: an update on the current and emerging treatment options

Lorenzo Ferro Desideri  1   2   3 , Dmitri Artemiev  4   5 , Souska Zandi  4   5   6 , Martin S Zinkernagel  4   5   6 , Rodrigo Anguita  4   5   7
Affiliations
Review

Proliferative vitreoretinopathy: an update on the current and emerging treatment options

Lorenzo Ferro Desideri et al. Graefes Arch Clin Exp Ophthalmol. 2024 Mar.

Abstract

Proliferative vitreoretinopathy (PVR) remains the main cause of failure in retinal detachment (RD) surgery and a demanding challenge for vitreoretinal surgeons. Despite the large improvements in surgical techniques and a better understanding of PVR pathogenesis in the last years, satisfactory anatomical and visual outcomes have not been provided yet. For this reason, several different adjunctive pharmacological agents have been investigated in combination with surgery. In this review, we analyze the current and emerging adjunctive treatment options for the management of PVR and we discuss their possible clinical application and beneficial role in this subgroup of patients.

Keywords: Methotrexate; PVR; Proliferative vitreoretinopathy; Steroids; Vitrectomy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Idrees S, Sridhar J, Kuriyan AE. Proliferative vitreoretinopathy: a review. Int Ophthalmol Clin. 2019;59:221–240. doi: 10.1097/IIO.0000000000000258. - DOI - PMC - PubMed
    1. Pastor JC, Rojas J, Pastor-Idoate S, et al. Proliferative vitreoretinopathy: a new concept of disease pathogenesis and practical consequences. Prog Retin Eye Res. 2016;51:125–155. doi: 10.1016/j.preteyeres.2015.07.005. - DOI - PubMed
    1. (1983) The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 90(2):121–125. 10.1016/s0161-6420(83)34588-7 - PubMed
    1. Machemer R, Aaberg TM, Freeman HM, et al. An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol. 1991;112:159–165. doi: 10.1016/S0002-9394(14)76695-4. - DOI - PubMed
    1. Claes C, Lafeta AP. Proliferative vitreoretinopathy. Dev Ophthalmol. 2014;54:188–195. doi: 10.1159/000360466. - DOI - PubMed

MeSH terms